Organon &
Stock Forecast, Prediction & Price Target
Organon & Financial Estimates
Organon & Revenue Estimates
Organon & EBITDA Estimates
Organon & Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $6.30B N/A | $6.17B -2.06% | $6.26B 1.44% | Avg: $6.46B Low: $6.39B High: $6.52B avg. 3.26% | Avg: $6.54B Low: $6.46B High: $6.62B avg. 1.15% | Avg: $6.20B Low: $6.13B High: $6.28B avg. -5.14% | Avg: $6.19B Low: $6.11B High: $6.26B avg. -0.24% |
Net Income
% change YoY
| $1.35B N/A | $917M -32.12% | $1.02B 11.55% | Avg: $971M Low: $946.26M High: $977.00M avg. -5.08% | Avg: $1.07B Low: $1.04B High: $1.07B avg. 10.29% | Avg: $1.10B Low: $1.08B High: $1.12B avg. 3.13% | Avg: $1.05B Low: $1.03B High: $1.06B avg. -4.87% |
EBITDA
% change YoY
| $1.81B N/A | $1.69B -6.83% | $1.43B -15.02% | Avg: $2.22B Low: $2.19B High: $2.24B avg. 54.76% | Avg: $2.24B Low: $2.22B High: $2.27B avg. 1.15% | Avg: $2.13B Low: $2.10B High: $2.15B avg. -5.14% | Avg: $2.12B Low: $2.10B High: $2.15B avg. -0.24% |
EPS
% change YoY
| $5.33 N/A | $3.61 -32.27% | $4.01 11.08% | Avg: $3.75 Low: $3.69 High: $3.81 avg. -6.48% | Avg: $4.13 Low: $4.07 High: $4.2 avg. 10.13% | Avg: $4.31 Low: $4.24 High: $4.38 avg. 4.35% | Avg: $4.1 Low: $4.04 High: $4.17 avg. -4.87% |
Operating Expenses
% change YoY
| $2.11B N/A | $2.17B 3.03% | $2.42B 11.31% | Avg: $1.59B Low: $1.57B High: $1.61B avg. -34.06% | Avg: $1.61B Low: $1.59B High: $1.63B avg. 1.15% | Avg: $1.53B Low: $1.51B High: $1.55B avg. -5.14% | Avg: $1.52B Low: $1.50B High: $1.54B avg. -0.24% |
FAQ
What is Organon & stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 0.86% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is 946.26M, average is 971M and high is 977.00M.
What is Organon & stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -0.24% in 2025-2028.
We have gathered data from 5 analysts. Their low revenue estimate is $6.39B, average is $6.46B and high is $6.52B.
What is Organon & stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 0.78% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is $3.69, average is $3.75 and high is $3.81.
What is the best performing analyst?
In the last twelve months analysts have been covering Organon & stock. The most successful analyst is David Amsellem.